TELL among the winners of the Legado 2025 contest!
TELL was among the winners of the Legado 2025 contest, organized by Bayer Foundation, Bayer, and Endeavor to find disruptive solutions for pressing global health challenges. For more details, click here.
Jeremías Inchauspe
Jeremías Inchauspe has a Bachelor’s degree in Psychology and a passion for language technologies. He is particularly interested in Natural Language Processing and Large Language Models, exploring how they can uncover meaningful patterns in speech and text. He is a doctoral researcher at the Centro de Neurociencias Cognitivas (UdeSA), where he develops text-based biomarkers for […]
Addressing Alzheimer’s: speech and smell tests may help to detect cognitive decline
Digital tests based on speech and smell are being developed to screen for cognitive decline, researchers told the Alzheimer’s Association International Conference in Toronto. Two speech apps are already some way down the road, testing several markers including speech speed, vocabulary and rhythm in different languages to establish a baseline for testing, a session convened […]
One of our studies, highlighted in Le Scienze
Our study on natural language processing markers of Italian speakers with Parkinson’s disease was highlighted in Le Scienze, the Italian edition of Scientific American. You can read the full article, in Italian, here.
Giving Kenya a voice: Digital speech biomarkers for brain health equity
Atlantic Fellows Adolfo Garcia and Chi‑Udeh‑Momoh—along with Fernando Johann, Vaibhav Narayan, Irene B. Meier, and Karen Blackmon—explore how digital speech biomarkers can advance brain health equity through innovative work in Kenya. You can read the full article here.
Detecting Parkinson’s disease through everyday handwriting (in Spanish)
Parkinson’s disease, the second most common neurodegenerative disorder worldwide, affects the central nervous system and progressively impairs motor control. Its characteristic symptoms include muscle stiffness, resting tremors, postural instability, and slowness of movement, which affects activities that require coordination, such as handwriting. This often presents specific alterations, including micrographia—an abnormal reduction in letter size—and dysgraphia—difficulties […]
We were featured on the Neurostartups podcast!
Our CSO, Dr. Adolfo García, was invited to the NeuroStartups podcast, by Neurotransmitiendo, to talk about TELL. To listen to the full episode, click here.
Advancing Chuck Feeney’s legacy through brain health innovation
Atlantic Fellows for Equity in Brain Health Corrina Grimes and Adolfo García reflect on their collaboration on MemoryTell—a speech-based platform making early, accessible dementia diagnosis a reality for more people.To read the full article, please click here.
Launch of MemoryTell in Ireland
TELL’s B2B model lands in Ireland through MemoryTell! Learn more about this effort led by GBHI Fellow Corrina Grimes here.
TELL partners with Hospital Evangélico, in Uruguay!
TELL partners with Hospital Evangélico, in Uruguay, to boost early detection of neurodegenerative disorders, promoting more accurate and timely brain health diagnoses.